[HTML][HTML] Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated …
…, SO Compán, M Alvarez-Mon, D Troncoso… - The Lancet Regional …, 2023 - thelancet.com
Background A SARS-CoV-2 protein-based heterodimer vaccine, PHH-1V, has been shown
to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study …
to be safe and well-tolerated in healthy young adults in a first-in-human, Phase I/IIa study …
[HTML][HTML] A predictive model and risk factors for case fatality of COVID-19
…, J Monserrat, MN Plana, D Troncoso… - Journal of personalized …, 2021 - mdpi.com
This study aimed to create an individualized analysis model of the risk of intensive care unit (ICU)
admission or death for coronavirus disease 2019 (COVID-19) patients as a tool for the …
admission or death for coronavirus disease 2019 (COVID-19) patients as a tool for the …
Prevalence and risk factors for mortality related to COVID-19 in a severely affected area of Madrid, Spain
…, AU Mathews, EL Ramos, LM Garcia, D Troncoso… - medRxiv, 2020 - medrxiv.org
BACKGROUND The coronavius disease 2019 (COVID-19) caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) reached Spain by 31 January 2020, in April …
respiratory syndrome coronavirus 2 (SARS-CoV-2) reached Spain by 31 January 2020, in April …
AIGuide: An augmented reality hand guidance application for people with visual impairments
Locating and grasping objects is a critical task in people’s daily lives. For people with visual
impairments, this task can be a daily struggle. The support of augmented reality frameworks …
impairments, this task can be a daily struggle. The support of augmented reality frameworks …
Sparse to dense depth completion using a generative adversarial network with intelligent sampling strategies
Predicting dense depth accurately is essential for 3D scene understanding applications
such as autonomous driving and robotics. However, the depth obtained from commercially …
such as autonomous driving and robotics. However, the depth obtained from commercially …
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
…, MJL Fernandez, M Alvarez-Mon, D Troncoso… - medRxiv, 2024 - medrxiv.org
The HIPRA-HH-2 was a multicentre, randomized, active-controlled, double-blind, non-inferiority
phase IIb clinical trial to compare the immunogenicity and safety of a heterologous …
phase IIb clinical trial to compare the immunogenicity and safety of a heterologous …
Machine Learning Techniques in Credit Default Prediction
E Malagon, D Troncoso, A Rubio, H Ponce - … International Conference on …, 2022 - Springer
Digital transformation after the pandemic is a must if a company wants to survive in a highly
competitive environment. Machine Learning (ML) applications are no strangers to Digital …
competitive environment. Machine Learning (ML) applications are no strangers to Digital …
La empresa social: realidad de la economía social en España
El objetivo de la investigación fue identificar el actual tejido socio empresarial de España,
así como detallar el perfil de la Empresa Social activa. En esta identificación, se planteó una …
así como detallar el perfil de la Empresa Social activa. En esta identificación, se planteó una …
Tocilizumab efficacy in COVID-19 patients is associated with respiratory severity-based stages
…, AG Garcia, A Pérez, M Herrero, N Plana, D Troncoso… - medRxiv, 2021 - medrxiv.org
Background Tocilizumab treatment is investigated, and effectiveness in ICU-admitted COVID-19
patients has been reported. Although controversy exists regarding the efficacy of …
patients has been reported. Although controversy exists regarding the efficacy of …
[HTML][HTML] Health economic assessment
…, DM Epstein, DP Troncoso… - … stimulation as an …, 2023 - ncbi.nlm.nih.gov
Burgess L, Smith S, Babber A, et al. Neuromuscular electrical stimulation as an adjunct to
standard care in improving walking distances in intermittent claudication patients: the NESIC …
standard care in improving walking distances in intermittent claudication patients: the NESIC …